Roche recently announced that it will invest $50 billion (€43.8 billion) into the United States in the next five years.

Thermo Fisher Scientific recently announced the grand opening of its Advanced Therapies Collaboration Center (ATxCC) in Carlsbad, California, US.

Cellasto, the world leader in Noise, Vibration and Harshness (NVH) components, is investing roughly €60 million to establish a second plant in Shanghai, China.

To meet growing demand from the pharmaceutical industry, Asahi Kasei has established Asahi Kasei Life Science to operate its bioprocess businesses under a new...

Novo Nordisk continues its sizeable manufacturing investments to meet increasing drug demands.

Solvay has officially inaugurated its rare earths production line for permanent magnets at the La Rochelle facility, marking a significant milestone in the Group’s...

NBE Therapeutics (NBE), a wholly owned subsidiary of  Boehringer Ingelheim, officially opened its new ADC R&D facility in Basel.

New facility will focus on crosslinkers and binders, with the potential to test tens of thousands of formulations per year. Digitalization and automation enable data...